AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « targeting »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
targeted < targeting < targets  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]
Ident.Authors (with country if any)Title
000020 (2011) Taras Gout [Royaume-Uni] ; Andrew J. K. Östör [Royaume-Uni] ; Muhammad K. Nisar [Royaume-Uni]Lower gastrointestinal perforation in rheumatoid arthritis patients treated with conventional DMARDs or tocilizumab: a systematic literature review
000057 (2007) Peter Taylor [Royaume-Uni]IL‐6 inhibition in the treatment of rheumatoid arthritis
000060 (2013) Francesco Caso [Italie] ; Luca Iaccarino [Italie] ; Silvano Bettio [Italie] ; Francesca Ometto [Italie] ; Luisa Costa [Italie] ; Leonardo Punzi [Italie] ; Andrea Doria [Italie]Refractory pemphigus foliaceus and Behçet’s disease successfully treated with tocilizumab
000069 (2016) Nozomu Yanaihara [Japon] ; Yukihiro Hirata [Japon] ; Noriko Yamaguchi [Japon] ; Yukiko Noguchi [Japon] ; Misato Saito [Japon] ; Chie Nagata [Japon] ; Satoshi Takakura [Japon] ; Kyosuke Yamada [Japon] ; Aikou Okamoto [Japon]Antitumor effects of interleukin‐6 (IL‐6)/interleukin‐6 receptor (IL‐6R) signaling pathway inhibition in clear cell carcinoma of the ovary
000072 (2014) Sabeeda Kadavath [États-Unis] ; Ekaterini Zapantis [États-Unis] ; Ronald Zolty [États-Unis] ; Petros Efthimiou [États-Unis]A novel therapeutic approach in pulmonary arterial hypertension as a complication of adult‐onset Still's disease: targeting IL‐6
000122 (2006) C. Christodoulou [Royaume-Uni] ; E. H. Choy [Royaume-Uni]Joint inflammation and cytokine inhibition in rheumatoid arthritis
000167 (2013) M. J. Kraakman [Australie] ; T. L. Allen [Australie] ; M. Whitham [Australie] ; P. Iliades [Australie] ; H. L. Kammoun [Australie] ; E. Estevez [Australie] ; G. I. Lancaster [Australie] ; M. A. Febbraio [Australie]Targeting gp130 to prevent inflammation and promote insulin action
000180 (2009) Guangjie Chen [République populaire de Chine]Immunotherapy of Rheumatoid Arthritis Targeting Inflammatory Cytokines and Autoreactive T Cells
000194 (2007) M. Schneider [Allemagne]Exploring new territory: considering the future
000227 (2006) Marcus D. Köller [Autriche]Targeted therapy in rheumatoid arthritis
000234 (2012) G. Lippi [Italie] ; G. Targher [Italie]Optimal therapy for reduction of lipoprotein(a)
000250 (2009) Luca Semerano [France] ; Marie-Christophe Boissier [France]Les anticorps monoclonaux dans les maladies immunes inflammatoires chroniques
000280 (2010) Valeria Bruno [Italie] ; Giuseppe Battaglia [Italie] ; Ferdinando Nicoletti [Italie]The advent of monoclonal antibodies in the treatment of chronic autoimmune diseases
000284 (2012) Usama Elewa [Espagne] ; Maria Dolores Sanchez-Ni O [Espagne] ; Catalina Martin-Cleary [Espagne] ; Beatriz Fernandez-Fernandez [Espagne] ; Jesus Egido [Espagne] ; Alberto Ortiz [Espagne]Cardiovascular risk biomarkers in CKD: the inflammation link and the road less traveled
000315 (2011) Kjell Tullus [Royaume-Uni]New developments in the treatment of systemic lupus erythematosus
000464 (2009) T. Pap [Allemagne]Aktuelle Trends in Design und Entwicklung monoklonaler Antikörper gegen Entzündungsmediatoren zur Therapie der rheumatoiden Arthritis
000584 (2012) Chia Chi Sun [États-Unis] ; Valentina Vaja [États-Unis, Italie] ; Jodie L. Babitt [États-Unis] ; Herbert Y. Lin [États-Unis]Targeting the hepcidin–ferroportin axis to develop new treatment strategies for anemia of chronic disease and anemia of inflammation
000600 (2010) Manfred Kopf [Suisse] ; Martin F. Bachmann [Suisse] ; Benjamin J. Marsland [Suisse]Averting inflammation by targeting the cytokine environment
000873 (2012) Eugenia K. Page [États-Unis] ; Wasim A. Dar [États-Unis] ; Stuart J. Knechtle [États-Unis]Biologics in organ transplantation
000958 (2009) Ewa M. Paleolog [Royaume-Uni]The vasculature in rheumatoid arthritis: cause or consequence?
000959 (2012) Mindy S. Lo [États-Unis] ; George C. Tsokos [États-Unis]Treatment of systemic lupus erythematosus: new advances in targeted therapy

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "targeting" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "targeting" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    targeting
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021